Clinical Drug Testing in Primary Care - Part 1

$20.00 | CE Hours:4.00 | Intermediate

Did you know you can now get UNLIMITED CE Hours for only $74.95?
Click Here to learn more.


CE Course Description

This course provides information that clinical practitioners need when deciding whether to introduce drug testing in their practices. It offers guidance on implementing drug testing, and describes some of the ways that drug testing can contribute to assessment, diagnosis, and treatment of patients seen in primary care. It also covers the management of the treatment of chronic pain, and the identification and treatment of substance use disorders.

Author:  Substance Abuse and Mental Health Services Administration.  (2012).  Clinical drug testing in primary care.  Technical Assistance Publication (TAP) 32.  HHS Publication No. SMA 12-4668.  Rockville, MD: Substance Abuse and Mental Health Services Administration.

References / Contributions by:

Black, D., & Andreasen, N.  (2011).  Introductory textbook of psychiatry (5th edition).  Washington, DC: American Psychiatric Publishing, Inc.

Bosker, W.M., & Huestis, M.A.  (2009).  Oral fluid testing for drugs of abuse.  Clinical Chemistry, 55(11), 1910-1931.

Christo, P., Manchikanti, L., Ruan, X., Bottros, M., Hansen, H., Solanki, D.R., et al.  (2011).  Urine drug testing in chronic pain.  Pain Physician, 14(2), 123-143.

Retrieved from:


CE Course Objectives

1.  Name three situations in which clinical drug testing can be used.

2.  Describe the relationship between clinical and workplace drug testing.

3.  Explain the first step in drug testing.

4.  List three factors that the window of detection depends on.

5.  Provide the advantages and disadvantages of using urine as a matrix for drug testing.


CE Outline with Main Points

1.  Introduction

a.  Reasons To Use Clinical Drug Testing in Primary Care

b.  Primary Care and Substance Use Disorders

c.  Development of Drug Testing

d.  Workplace Drug Testing

e.  Drug Testing in Substance Abuse Treatment and Healthcare Settings

f.  Differences Between Federal Workplace Drug Testing and Clinical Drug Testing

g.  Caution

2.  Terminology and Essential Concepts in Drug Testing

a.  Drug Screening and Confirmatory Testing

b.  Testing Methods

c.  Test Reliability

d.  Window of Detection

e.  Cutoff Concentrations

f.  Cross-Reactivity

g.  Drug Test Panels

h.  Test Matrix

i.  Point-of-Care Tests

j.  Adulterants

k.  Specimen Validity Tests

3.  Preparing for Drug Testing

a.  Deciding Which Drugs To Screen and Test for

b.  Choosing a Matrix

c.  Selecting the Initial Testing Site: Laboratory or Point-of-Care

d.  Preparing a Specimen Collection Site



Social Work Approval

Social Work CE Credit for this course is offered with the following approvals. Many state boards of social work will accept the approvals listed. Provider Approvals by state and license type can be found here.

  • Quantum Units Education is approved by the California Association of Marriage and Family Therapists, CAMFT Provider #89970, to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEP. Quantum Units Education maintains responsibility for this program/course and its content.
  • Florida board for Social Workers CE Provider #50-8650 (Quantum 'immediately' reports CE Credits to Florida licensees) 
  • Illinois Department of Professional Regulation, License No. 159.001261 approved CE Sponsor
  • Ohio CSWMFTB #RCST091701 approved CE Provider
  • Texas Board of SWE #5070 approved CE Provider
  • ACE credit is offered for this course for social workers (followed by ACE approval statement that is currently on every ACE course page) Quantum Units Education, #1289, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. Quantum Units Education maintains responsibility for this course. ACE provider approval period: 01/03/2020 – 01/03/2023.

To see other approvals in your state, see our state by state provider approval listings here.


Course Development: Each course is identified and reviewed by the appropriate Quantum Units Education consultant with professional and licensed expertise in the various disciplines we serve. Our professional consultants oversee course development to satisfy the needs of various professionals based on their board requirements, rate course degrees of difficulty and ensure the course content and exam questions are appropriate, relevant and comprehensive. See our professional staff and their bios here.

*Questions regarding how to take a course, refunds, grievance policy and ADA policy can be found here.
*Questions regarding this course or need support? Contact us at

Added On: 2019-10-23

Powered by LIFTOFF Digital | Web Design and Development